Eton Pharmaceuticals, Inc. is a specialized pharmaceutical firm located in Deer Park, Illinois, dedicated to the development and commercialization of innovative therapies for rare diseases. The company has a robust pipeline of proprietary products addressing significant unmet medical needs, thereby aiming to enhance patient outcomes in underserved markets. Eton's strategic focus on research and development, along with its collaborative partnerships, establishes it as a key competitor in the pharmaceutical landscape, well-positioned for growth in niche markets that present limited competition and substantial opportunities. Show more

Location: 21925 W. FIELD PARKWAY, DEER PARK, IL, UNITED STATES, 60010-7278, Deer Park, IL, 60010-7278, USA | Website: https://www.etonpharma.com | Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC | Sector: HEALTHCARE

Market Cap

402.5M

52 Wk Range

$11.09 - $23.00

Previous Close

$15.25

Open

$15.21

Volume

176,183

Day Range

$14.97 - $15.40

Enterprise Value

396.3M

Cash

37.12M

Avg Qtr Burn

N/A

Insider Ownership

4.36%

Institutional Own.

65.89%

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
ZONISADE (Zonisamide) (ET-104) Details Rare genetic disease, Neurological disorder	Approved Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Betaine Anhydrous (Betaine Anhydrous) (Methyl Donor) Details Homocystinuria	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Biorphen® (phenylephrine HCI) Details Hypotension (vasodilation in the setting of anesthesia)	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ALKINDI® SPRINKLE (hydrocortisone) Details Adrenocortical Insufficiency (Pediatrics)	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Alaway® Preservative Free (ketotifen fumarate) ophthalmic solution, 0.035%, antihistamine eye drops (EM-100) Details Itchy Eyes Associated with Allergies	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
GALZIN/Zinc Acetate (Zinc Acetate) (Copper Chelator) Details Wilson Disease	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
GALZIN/Zinc Acetate (Zinc Acetate) (Copper Chelator) Details Wilson Disease	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
PKU GOLIKE (PKU GOLIKE) (Medical Food) Details Phenylketonuria	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
KHINDIVI™ (hydrocortisone) Oral Solution Details Pediatric Adrenocortical Insufficiency	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Cysteine hydrochloride injection (generic - ANDA) Details Additive to amino acid solutions to meet the nutritional requirements of newborn infants	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Nitisinone Capsules Details Tyrosinemia type 1, Rare diseases	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Rezipres (Ephedrine Injection) (ET-203) Details Injectable hospital-use product	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
EPRONTIA (Topiramate Oral Solution) (ET-101) Details Tonic-clonic seizures / seizures / migraine	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Carbaglu® (carglumic acid tablets) Details Hyperammonemia NAGS deficient, chronic hyperammonemia	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ET-600 (Desmopressin Oral Solution) Details Diabetes insipidus	PDUFA Approval decision	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ZENEO Hydrocortisone (ZENEO Hydrocortisone) (Corticosteroid Injection) Details Adrenal Crisis	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ET-800 (Extended-Release Drug) Details Adrenal insufficiency	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Amglidia/Glibenclamide (Glibenclamide) (Sulfonylurea Agent) Details Neonatal Diabetes	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
INCRELEX/Mecasermin (Mecasermin) (IGF-1 Agonist) Details Severe Primary IGF-1 Deficiency Label Expansion	Phase 1 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ET-700 (Extended-Release Drug) Details Undisclosed Indication	Phase 1 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ET-700 (Extended-Release Drug) Details Undisclosed Indication	Phase 1 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Dehydrated Alcohol Injection (DS-100) Details Methanol poisoning	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Lamotrigine Oral Suspension (ET-105) Details Seizures, Epilepsy, Lennox-Gastaut syndrome	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.